D.E. Shaw & Co
IDXX icon

D.E. Shaw & Co’s Idexx Laboratories IDXX Stock Holding History

D.E. Shaw & Co’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,600
Closed -$1.02M – 4777
2025
Q3 		$1.02M Buy
+1,600
New +$971K ﹤0.01% 3437
2025
Q2 		– Sell
-5,100
Closed -$2.14M – 4501
2025
Q1 		$2.14M Sell
5,100
-3,900
-43% -$1.69M ﹤0.01% 2556
2024
Q4 		$3.72M Buy
9,000
+4,900
+120% +$2.15M ﹤0.01% 2226
2024
Q3 		$2.07M Buy
4,100
+3,000
+273% +$1.46M ﹤0.01% 2690
2024
Q2 		$536K Buy
+1,100
New +$552K ﹤0.01% 3583
2022
Q4 		– Sell
-14,000
Closed -$4.56M – 4968
2022
Q3 		$4.56M Buy
14,000
+4,000
+40% +$1.47M 0.01% 2202
2022
Q2 		$3.51M Sell
10,000
-10,900
-52% -$4.44M ﹤0.01% 2559
2022
Q1 		$11.4M Buy
+20,900
New +$11M 0.01% 1484
2021
Q4 		– Sell
-10,000
Closed -$6.22M – 5533
2021
Q3 		$6.22M Buy
+10,000
New +$6.72M 0.01% 1901
2018
Q4 		– Sell
-5,000
Closed -$1.25M – 3863
2018
Q3 		$1.25M Buy
+5,000
New +$1.21M ﹤0.01% 2537
2014
Q1 		– Sell
-20,000
Closed -$1.06M – 4434
2013
Q4 		$1.06M Hold
20,000
– – ﹤0.01% 3118
2013
Q3 		$997K Hold
20,000
– – ﹤0.01% 3042
2013
Q2 		$898K Buy
+20,000
New +$874K ﹤0.01% 2806

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

D.E. Shaw & Co's IDXX Position: Q2 2026 in Review

D.E. Shaw & Co sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 1,074 shares — an estimated $603K sold.

D.E. Shaw & Co first reported a position in IDXX in Q2 2013 and held it in 41 quarters. The position peaked at $100M in Q1 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • D.E. Shaw & Co reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,074 Idexx Laboratories shares in Q2 2026, an estimated $603K.
  • D.E. Shaw & Co first reported a position in Idexx Laboratories in Q2 2013 and held it in 41 quarters.
  • D.E. Shaw & Co's Idexx Laboratories position peaked at $100M in Q1 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.